Crossmark

Authors’ Reply to Braillon and Martin’s Comment on “Proposals for Engaging Patients and Healthcare Professionals in Risk Minimisation from an Analysis of Stakeholder Input to the EU Valproate Assessment using the Novel Analysing Stakeholder Safety Engagement Tool (ASSET)”

Crossref DOI link: https://doi.org/10.1007/s40264-021-01096-6

Published Online: 2021-07-29

Published Print: 2021-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Bahri, Priya

Morales, Daniel R.

Inoubli, Adrien

Dogné, Jean-Michel

Straus, Sabine M. J. M.
License Information

Text and Data Mining valid from 2021-07-29

Version of Record valid from 2021-07-29
More Information

Article History

Accepted: 4 July 2021

First Online: 29 July 2021

Declarations

: The views expressed in this response are the authors’ personal views and may not be understood or quoted as being made on behalf of or reflect the position of the EMA or one of its committees or working parties.

: No specific funding was received for the conduct of this response.

: Priya Bahri, Daniel R. Morales, Adrien Inoubli, Jean-Michel Dogné and Sabine M.J.M. Straus have no conflicts of interests that are directly relevant to the content of this response.

: Not applicable.

: Not applicable.

: Not applicable.

: The study [CitationRef removed] used the records described and referenced with the access option as applicable in Sect. 2 Methods and the data analyses are provided in Appendix 3 online.

: Not applicable.

: All authors participated in preparing this response and approved the final version.

Document is current

Any future updates will be listed below